{"id":4231,"date":"2026-03-17T15:54:25","date_gmt":"2026-03-17T15:54:25","guid":{"rendered":"https:\/\/www.perimed-instruments.com\/us\/?p=4231"},"modified":"2026-03-17T16:18:27","modified_gmt":"2026-03-17T16:18:27","slug":"change-in-medtech-is-inevitable-managing-it-ensures-continuity-for-our-customers","status":"publish","type":"post","link":"https:\/\/www.perimed-instruments.com\/us\/blog\/change-in-medtech-is-inevitable-managing-it-ensures-continuity-for-our-customers\/","title":{"rendered":"Change in medtech is inevitable \u2014 managing it ensures continuity for our customers"},"content":{"rendered":"
\n <\/div>\n\n\n\n
\n
\n

by Jimmy Bakker<\/a> (Product Manager<\/em>)<\/p>\n\n\n\n

Recently, we upgraded the touchscreen interface of our perfusion monitor, PeriFlux 6000. While this may not sound revolutionary, the path from an end-of-life notification to a new component in production made me reflect on what it means to manage change in medtech.<\/p>\n\n\n\n

As product manager, my responsibility is to ensure that our systems keep pace with the evolving needs of clinicians and researchers, advances in technology and materials, and an increasingly complex, changing regulatory and cybersecurity landscape.<\/p>\n\n\n\n

In this post, I will share Perimed\u2019s approach to change management \u2014 and how we design it to deliver the best outcomes for our customers, their patients, and our internal teams \u2014 using the touchscreen transitions as a practical example.<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n
\n <\/div>\n\n\n
\n \n\n
\n \n\n
\n
\n <\/div>\n\n\n\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n
\n

All change comes from necessity<\/h3>\n <\/div>\n\n\n\n

There is always a driver.  Sometimes it\u2019s obvious: new clinical insights, updated regulations, or technological breakthroughs. Other times, the driver is quieter, almost invisible, like when a component reaches end-of-life<\/strong>.  <\/p>\n\n\n\n

This was the case for our touchscreen. The supplier informed us that the component we had been using would soon no longer be available \u2014 a clear signal to act. In a regulated environment like ours, such notifications are critical, giving us the lead time needed to plan and implement change in a structured way.<\/p>\n\n\n\n

The touchscreen transition change became part of a broader hardware initiative, addressing additional capabilities \u2014 some of which have already been released: What’s new in PeriFlux 6000<\/mark><\/a>
<\/p>\n\n\n\n

\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n <\/div>\n <\/section>\n\n\n
\n <\/div>\n\n\n
\n \n\n
\n \n\n
\n
\n

Managing change holistically<\/h3>\n <\/div>\n\n\n\n
\n

A holistic approach allows us to avoid the pitfalls of managing change in isolation and uncover synergies. It enables us to remain agile while delivering updates in a controlled and reliable way.<\/p>\n\n\n\n

When a component reaches end-of-life, the primary objective is to secure continuity of supply. From there, the key question becomes: do we implement a like-for-like replacement or take the opportunity to introduce a broader upgrade.<\/p>\n\n\n\n

Even a seemingly straightforward replacement requires careful evaluation.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n

In medtech, this evaluation spans multiple dimensions, not least the materials used. For the touchscreen, we assessed:<\/p>\n\n\n\n